Hydroxyurea-Induced Apoptosis in an EBV-Immortalized Lymphoblastoid Cell Line

Oncology Research

Volumn 14, Issue 4-5, 2003, Pages 235-245

  Huyghe, Pauline ^a,b   Dassonneville, Laurent ^a   Fenaux, Pierre ^a,b,c   Bailly, Christian ^a  

^a Institut de Recherche sur le Cancer de Lille   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

Apoptosis; Bcl 2; Cell cycle; Hydroxyurea; p53

Indexed keywords

BROXURIDINE; CASPASE; DNA; DNA FRAGMENT; HYDROXYUREA; LIPOCORTIN 5; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL IMMORTALIZATION; CELL MEMBRANE; CELL POPULATION; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; CYTOTOXICITY; DIPLOIDY; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOBLASTOID CELL LINE; MYELOID LEUKEMIA; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 1442354057     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003772505362     Document Type: Article

References (36)

1. Navarra, P.; Preziosi, P. Hydroxyurea: New insights on an old drug. Crit. Rev. Oncol. Hematol. 29:249-255; 1999.
2. Fadilah, S. A.; hmad-Zailani, H.; Soon-Keng, C.; Norlaila, M. Successful treatment of chronic myeloid leukemia during pregnancy with hydroxyurea. Leukemia 16:1202-1203; 2002.
3. Najean, Y.; Rain, J. D. Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 90:3370-3377; 1997.
4. Solberg, L. A., Jr. Therapeutic options for essential thrombocythemia and polycythemia vera. Semin. Oncol. 29:10-15; 2002.
5. Newton, H. B.; Slivka, M. A.; Stevens, C. Hydroxyurea chemotherapy for unresectable or residual meningioma. J. Neurooncol. 49:165-170; 2000.
6. Mason, W. P.; Gentili, F.; Macdonald, D. R.; Hariharan, S.; Cruz, C. R.; Abrey, L. E. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma. J. Neurosurg. 97:341-346; 2002.
7. Ballas, S. K. Sickle cell anaemia: Progress in pathogenesis and treatment. Drugs 62:1143-1172; 2002.
8. Balzarini, J. Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors. Pharmacol. Ther. 87:175-187; 2000.
9. Lafeuillade, A.; Hittinger, G.; Chadapaud, S.; Maillefet, S.; Rieu, A.; Poggi, C. The HYDILE trial: Efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations. HIV Clin. Trials 3:263-271; 2002.
10. Jiang, J.; Jordan, S. J.; Barr, D. P.; Gunther, M. R., Maeda, H.; Mason, R. P. In vivo production of nitric oxide in rats after administration of hydroxyurea. Mol. Pharmacol. 52:1081-1086; 1997.
11. Tomita, K.; Plager, J. E. In vivo cell cycle synchronization of the murine sarcoma 180 tumor following alternating periods of hydroxyurea blockade and release. Cancer Res. 39:4407-4411; 1979.
12. Sakano, K.; Oikawa, S.; Hasegawa, K.; Kawanishi, S. Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide. Jpn. J. Cancer Res. 92:1166-1174; 2001.
13. Navarra, P.; Puccetti, P.; Riccardi, C.; Preziosi, P. Anticancer drug toxicity via cytokine production. The hydroxyurea paradigm. Toxicol. Lett. 82-83:167-171; 1995.
14. Navarra, P.; Grohmann, U.; Nocentini, G.; Tringali, G.; Puccetti, P.; Riccardi, C.; Preziosi, P. Hydroxyurea induces the gene expression and synthesis of proinflammatory cytokines in vivo. J. Pharmacol. Exp. Ther. 280:477-482; 1997.
15. Schrell, U. M.; Rittig, M. G.; Anders, M.; Kiesewetter, F.; Marschalek, R.; Koch, U. H.; Fahlbusch, R. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma. cells in culture and in meningioma transplants by induction of the apoptotic pathway. J. Neurosurg. 86:845-852; 1997.
16. Johnson, C. A.; Forster, T. H.; Winterford, C. M.; Allan, D. J. Hydroxyurea induces apoptosis and regular DNA fragmentation in a Burkitt's lymphoma cell line. Biochim. Biophys. Acta 1136:1-4; 1992.
17. Gui, C. Y.; Jiang, C.; Xie, H. Y.; Qian, R. L. The apoptosis of HEL cells induced by hydroxyurea. Cell Res. 7: 91-97; 1997.
18. Shin, J. H.; Mori, C.; Shiota, K. Involvement of germ cell apoptosis in the induction of testicular toxicity following hydroxyurea treatment. Toxicol. Appl. Pharmacol. 155: 139-149; 1999.
19. Anand, S.; Verma, H.; Kumar, L.; Singh, N. Induction of apoptosis in chronic myelogenous leukemia lymphocytes by hydroxyurea and adriamycin. Cancer Lett. 88:101-105; 1995.
20. Dacie, J. V.; Lewis, S. M. Practical haematology, 6th ed. Edinburgh: Churchill Livingstone; 1984:50-56.
21. Macedo, A.; Orfao, A.; Ciudad, J.; Gonzalez, M.; Vidriales, B.; Lopez-Berges, M. C.; Martinez, A.; Landolfi, C.; Cañizo, C.; San Miguel, J. F. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukemia 9:1896-1901; 1995.
22. Bene, M. C.; Castoldi, G.; Knapp, W.; Ludwig, W. D.; Matutes, E.; Orfao, A.; Van'tVeer, M. B. for the European Group for the Immunological Characterization of Leukemias (EGIL). Proposal for the immunological classification of acute leukemias. Leukemia 9:1783-1786; 1995.
23. Mitelman, F. ISCN: An international system for human cytogenetic nomenclature. Basel, Switzerland: Karger; 1995.
24. Sterkers, Y.; Preudhomme, C.; Lai, J.-L.; Demory, J.-L.; Caulier, M.-T.; Wattel, E.; Bordessoule, D.; Bauters, F.; Fenaux, P. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: High proportion of cases with 17p deletion. Blood 91:616-622; 1998.
25. Kluza, J.; Lansiaux, A.; Wattez, N.; Mahieu, C.; Osheroff, N.; Bailly, C. Apoptotic response of HL-60 human leukemia cells to the antitumor drug TAS-103. Cancer Res. 60: 4077-4084; 2000.
26. Merlat, A.; Lai, J.-L.; Sterkers, Y.; Demory, J.-L.; Bauters, F.; Preudhomme, C.; Fenaux, P. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases. Leukemia 13:250-257; 1999.
27. Stillman, W. S.; Varella-Garcia, M.; Gruntmair, J. J.; Irons, R. D. The benzene metabolite, hydroquinone, induces dose-dependent hypoploidy in a human cell line. Leukemia 11:1540-1545; 1997.
28. Zwaal, R. F.; Schroit, A. J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121-1132; 1997.
29. Fadok, V. A.; Bratton, D. L.; Frasch, S. C.; Warner, M. L.; Henson, P. M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5:551-562; 1998.
30. Boersma, A. W.; Nooter, K.; Oostrum, R. G.; Stoter, G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 24:123-130; 1996.
31. Rodriguez, G. I.; Kuhn, J. G.; Weiss, G. R.; Hilsenbeck, S. G.; Eckardt, J. R.; Thurman, A.; Rinaldi, D. A.; Hodges, S.; Von Hoff, D. D.; Rowinsky, E. K. A bioavailability and pharmacokinetic study of oral and intravenous hydroxyurea. Blood 91:1533-1541; 1998.
32. Yeo, E. J.; Hwang, Y. C.; Kang, C. M.; Kim, I. H.; Kim, D. I.; Parka, J. S.; Choy, H. E.; Park, W. Y.; Park S. C. Senescence-like changes induced by hydroxyurea in human diploid fibroblasts. Exp. Gerontol. 35:553-571; 2000.
33. Greenwood, S. K.; Armstrong, M. J.; Hill, R.B.; Bradt, C. I.; Johnson, T. E.; Hilliard, C. A.; Galloway, S. M. Fewer chromosome aberrations and earlier apoptosis induced by DNA synthesis inhibitors, a topoisomerase II inhibitor or alkylating agents in human cells with normal compared with mutant p53. Mutat. Res. 401:39-53; 1998.
34. Yang, E.; Korsmeyer, S. J. Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 88:386-401; 1996.
35. Torok, N. J.; Higuchi, H.; Bronk, S.; Gores, G. J. Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res. 62:1648-1653; 2002.
36. Bruchova, H.; Borovanova, T.; Klamova, H.; Brdicka, R. Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. Leuk. Lymphoma 43: 1289-1295; 2002.